» Articles » PMID: 28443260

Growth Without Growth Hormone in Combined Pituitary Hormone Deficiency Caused by Pituitary Stalk Interruption Syndrome

Overview
Specialty Pediatrics
Date 2017 Apr 27
PMID 28443260
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Growth hormone (GH) is an essential element for normal growth. However, reports of normal growth without GH have been made in patients who have undergone brain surgery for craniopharyngioma. Normal growth without GH can be explained by hyperinsulinemia, hyperprolactinemia, elevated leptin levels, and GH variants; however, its exact mechanism has not been elucidated yet. We diagnosed a female patient aged 13 with combined pituitary hormone deficiency (CPHD) caused by pituitary stalk interruption syndrome (PSIS). The patient has experienced recurrent hypoglycemic seizures since birth, but reached the height of 160 cm at the age of 13, showing normal growth. She grew another 8 cm for 3 years after the diagnosis, and she reached her final adult height of 168 cm which was greater than the midparental height, at the age of 16. The patient's blood GH and insulin-like growth factor-I levels were consistently subnormal, although her insulin levels were normal. Her physical examination conducted at the age of 15 showed truncal obesity, dyslipidemia, and osteoporosis, which are metabolic features of GH deficiency (GHD). Herein, we report a case in which a PSIS-induced CPHD patient attained her final height above mid parental height despite a severe GHD.

Citing Articles

Pituitary stalk interruption syndrome with coexistent focal cortical dysplasia in a young boy.

Alaqili A, Jadah R, Alkhayyat H BMJ Case Rep. 2025; 18(1.

PMID: 39809477 PMC: 11751600. DOI: 10.1136/bcr-2024-262020.


A rare case of pituitary stalk interruption syndrome (PSIS) presenting as short stature in an 8-year-old female.

Sen K, Bhandari K, Simkhada S, Humagain K, Basnet P, Shah P Clin Case Rep. 2024; 12(8):e9274.

PMID: 39109310 PMC: 11300814. DOI: 10.1002/ccr3.9274.


Clinical Features and Analysis in Pituitary Stalk Interruption Syndrome.

Guo Q, Zhao J, Yu S Int J Endocrinol. 2024; 2024:2493083.

PMID: 38828392 PMC: 11142856. DOI: 10.1155/2024/2493083.


Pituitary Stalk Interruption Syndrome with Excessive Height Growth Combined with Congenital Absence of the Uterus and Ovaries: A Rare Case Report and Review of the Literature.

Wu R, Xu J Diabetes Metab Syndr Obes. 2024; 17:1739-1747.

PMID: 38645656 PMC: 11032157. DOI: 10.2147/DMSO.S456678.


Pituitary stalk interruption syndrome and liver cirrhosis associated with diabetes and an inactivating gene mutation: a case report and literature review.

Liu Z, Zhao W, Cao C, Wang Y, Xiao L, Wang X Front Endocrinol (Lausanne). 2023; 14:1297146.

PMID: 38152125 PMC: 10751576. DOI: 10.3389/fendo.2023.1297146.


References
1.
Lazar L, Dan S, Phillip M . Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary hormone deficiency. Clin Endocrinol (Oxf). 2003; 59(1):82-8. DOI: 10.1046/j.1365-2265.2003.01805.x. View

2.
Holmes L, FRANTZ A, Rabkin M, Soeldner J, Crawford J . Normal growth with subnormal growth-hormone levels. N Engl J Med. 1968; 279(11):559-66. DOI: 10.1056/NEJM196809122791101. View

3.
Geffner M . The growth without growth hormone syndrome. Endocrinol Metab Clin North Am. 1996; 25(3):649-63. DOI: 10.1016/s0889-8529(05)70345-5. View

4.
Arroyo A, Pernasetti F, Vasilyev V, Amato P, Yen S, Mellon P . A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf). 2002; 57(2):283-91. PMC: 2932477. DOI: 10.1046/j.1365-2265.2002.01550.x. View

5.
Murashita M, Tajima T, Nakae J, Shinohara N, Geffner M, Fujieda K . Near-normal linear growth in the setting of markedly reduced growth hormone and IGF-1. A case report. Horm Res. 1999; 51(4):184-8. DOI: 10.1159/000023355. View